Logo

AURO LABORATORIES LTD. Share Price

BSE: 530233
|
Pharmaceuticals
₹ 255.00
+₹0.80 (0.31%)
1D
Last updated 03 Jul, 2026, 15:27 IST

AURO LABORATORIES LTD. Share Price Today

As of 5 Jul 2026, AURO LABORATORIES LTD. share price is ₹255.00. The stock opened at ₹255.00, compared to its previous close of ₹254.20. During today's trading session, AURO LABORATORIES LTD. share price moved in the range of ₹253.20 to ₹259.50, with an average price of ₹256.35 for the day. Looking at its last 52-week, the stock has touched a low of ₹159.00 and a high of ₹317.00.


₹253.20
0.31% up today
₹259.50
1D LOW
1D HIGH

AURO LABORATORIES LTD. Returns Calculator

Open
₹255.00
High
₹259.50
Low
₹253.20
Prev. close
₹254.20

Circuit
L
H
₹229.50
₹280.50
52-week
L
H
₹159.00
₹317.00

AURO LABORATORIES LTD. Shareholder Returns

AURO LABORATORIES LTD. Share Price History

Mkt Cap Cr
158.43

P/E
86.17

P/B
3.69

ROE
4.47%

D/E
1.37

ROCE
7.31%

Div. Yield
0.00%

EPS(TTM)
5.67
Turnover
0.33

EV/EBITDA
32.07

Net Margin
0.00%

Op. Margin
0.00%

ROA
1.55%

Quick Ratio
0.00

Curr. Ratio
3.59
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Auro Labs. has not beaten FD return of 7%
Step 1 of 5
Valuation
Overvalued
Auro Labs. appears overvalued compared to its peers
Step 3 of 5
Earnings
Neutral
Auro Labs. earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,49,048.0039.025.3713.74%0.6117.33%93.240.85%0.5610.90
Divis Laboratories1,77,179.0069.0010.5715.32%0.0019.56%629.490.45%0.5898.19
Torrent Pharmaceuticals1,57,804.0066.0317.0326.76%1.0518.30%16.900.90%0.4964.75
Cipla1,17,642.0025.472.8711.79%0.0015.66%2.891.06%0.4943.52
Dr. Reddy's Laboratories1,12,368.0027.032.9711.07%0.1812.54%375.780.59%0.6338.68
Zydus Lifesciences1,10,651.0021.604.0818.59%0.3117.35%235.250.09%0.3935.38
Lupin1,09,676.0020.484.8923.76%0.0424.88%659.050.75%0.61129.18
Mankind Pharma1,02,729.0053.006.3011.74%0.3413.13%397.020.04%0.5449.37
Aurobindo Pharma90,608.0025.872.399.25%0.1911.76%391.140.26%0.4841.58
Laurus Labs82,398.9060.2610.1018.21%0.4516.70%10.190.20%0.9713.72

AURO LABORATORIES LTD. Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2025
Revenue20.06
Operating profit1.88
Net profit1.84

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹19.40₹53.64₹52.89₹50.87
Other Income₹0.66₹1.50₹0.94₹1.09
Total Revenue₹20.05₹55.14₹53.84₹51.96
Total Expenses₹18.17₹44.79₹50.39₹48.08
Profit Before Tax₹1.88₹10.35₹3.45₹3.87
Tax₹0.04₹2.55₹1.00₹1.03
Profit After Tax₹1.84₹7.79₹2.44₹2.84
EPS - Basic₹2.95₹12.50₹3.92₹4.56
EPS - Diluted₹2.95₹12.50₹3.92₹4.56

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹1.88₹10.35₹3.45₹3.87
Income before WC changes₹3.78₹12.43₹5.58₹5.48
Change in Assets₹8.32₹4.04-₹8.01-₹11.62
Change in Liabilities-₹6.36₹2.34₹5.72-₹0.45
Change in WC₹1.96₹6.38-₹2.30-₹12.07
Cash flow from Operations₹5.75₹18.81₹3.28-₹6.59
Cash flow from Investing-₹24.45-₹38.67-₹5.08-₹5.34
Cash flow from Financing₹17.69₹19.09-₹8.18₹9.79
Total Cash Flow-₹1.02-₹0.77-₹9.98-₹2.14
Cash (Start of the year)₹1.65₹2.42₹12.40₹14.54
Cash (End of the year)₹0.63₹1.65₹2.42₹12.40

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹77.58₹54.88₹20.33₹17.33
Current Assets₹21.51₹30.85₹35.66₹37.63
Total Assets₹99.10₹85.73₹55.99₹54.96
Current Liabilities₹21.64₹23.93₹18.13₹20.13
Net Current Asset-₹0.13₹6.92₹17.53₹17.50
Non-Current Liabilities₹34.49₹19.84₹3.66₹3.31
Equity Capital₹42.97₹41.96₹34.20₹31.52
Total Equity & Liabilities₹99.10₹85.73₹55.99₹54.96
* All values are in INR Crore
Qty
Bid
1
255
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 1
Ask Total: 0
Buy orders: 100%
Sell orders: 0%
Bearish
1
Neutral
5
Bullish
2
Slightly Bullish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict

RSI (14)
46.75
Neutral

ATR (14)
12.03
Neutral

STOCH(9,6)
35
Neutral

STOCH RSI (14)
47.71
Neutral

ADX(9)
12.41
Bullish

UO(9)
29.2
Bullish

ROC(12)
-1.89
Bearish

WillR(14)
-72.13
Neutral
Period
Simple value
Exponential vaue

5D
254.88
255.03

10D
254.33
255.46

20D
256.3
257.05

50D
259.79
260.17

100D
269.19
259.39

About AURO LABORATORIES LTD.

AURO LABORATORIES LTD. logo
ISIN
INE292C01011
Sector Market Cap
₹ 158.43 Cr

Auro Laboratories Limited is an India-based company, which is engaged in the manufacturing activities of active pharmaceutical ingredients (APIs). The Company is specializing in producing anti-diabetics like Metformin HCL, which is used in the treatment of type 2 diabetes. It also undertakes toll/custom manufacturing for API's and intermediates on a contract basis. The Company's API products include antihistamine, muscle relaxant, diuretic, iron deficiency, anti-diabetics, anti-fungal, anti-ulcer, iodine supplement, anti-malaria, analgesics, antacids, anti-inflammatory, specialty chemicals and others. Its intermediate products include glibenclamde sulphonamide, cis-bramo benzoate, cls-tosylate, 2-ethoxy benzoic acid, 2-ethoxy benzoic acid, among others. It offers its manufacturing and technical services, such as process scale up, process optimization, custom synthesis and custom manufacturing. It exports to Southeast Asia, Middle East and several European countries.

AURO LABORATORIES LTD. Quarterly Result Highlights

  • AURO LABORATORIES LTD. reported revenue of ₹9.82 crore in Sep 2025, compared with ₹3.19 crore in Jun 2025, representing an increase of 207.84% on a quarter-on-quarter (QoQ) basis.
  • AURO LABORATORIES LTD. reported an operating profit of ₹1.72 crore in Sep 2025, compared with ₹0.11 crore in Jun 2025, representing an increase of 1,663.64% on a quarter-on-quarter (QoQ) basis.
  • AURO LABORATORIES LTD. reported a profit of ₹0.72 crore in Sep 2025, compared with ₹0.11 crore in Jun 2025, reflecting an increase of 754.55% on a QoQ basis.
Know more
Promoters
52.18%
FII
0.00%
Other DII
0.00%
Retail and other
47.82%
Mutual funds
0.01%
Foreign institutions - FII
Compare against other stocks
AURO LABORATORIES LTD. logo
AURO LABORATORIES LTD.
Pharmaceuticals
Add Stock
Add Another

FAQs on AURO LABORATORIES LTD. Share Price